Our published studies demonstrate that ChlA-F, a novel conformational derivative of the isolate Cheliensisin A (Chel A), remarkably inhibits the invasive ability of human invasive BC cells through downregulation of SOX2 protein expression, indicating that SOX2 plays an oncogenic role in human BC [30]. This evidence concerns the gene SOX2 and breast cancer.